ABBV

Trade of the Day: Halozyme Therapeutics, Inc. (NASDAQ:HALO)

he current market cap for Halozyme Therapeutics (HALO) is at $1.5 billion, which makes it ripe as a takeover target. More 

30 Stocks With “Safe” Growing Dividends

Looking at dividend yields alone won't cut it for investors. Safety is a key for dividend stock players, and these 30 "safe" dividend stocks fit the bill More 

Allergan, Pfizer Inc. Fall Prey to Tax-Inversion Hawks (AGN, PFE)

Pfizer (PFE) and Allergan (AGN) could still team up if they wanted to, but with new Treasury rules in place, why would they want to? More 

8 High-Quality, High-Dividend Stocks to Buy for Q2

A growth-strapped market is going to make high-dividend stocks crucial to investors for the foreseeable future. These income-driving stocks might be the only way to make good money for the rest of the year. More 

7 Low-Risk Healthcare Stocks to Buy Now

If you're looking for solid stocks to buy in an uncertain market, healthcare offers built-in growth and, often, safe dividends. More 

5 High-Yield Dividend Aristocrats to Buy Now

These high-quality, high-yield dividend aristocrats provide a source of safe income that actually has some teeth. And they're even attractively priced. More 

AbbVie Inc (ABBV) Is About to Steamroll the Competition

Good news for AbbVie (ABBV) shareholders: The pharmaceutical company just entered the Hepatitis C. market, while reinforcing its position in the psoriasis area. Given ABBV's knack for churning out blockbusters, these new additions are likely to be hits. More